文献速递肿瘤 PET/CT放射性药物与辐射防护

放射治疗后18F-FDG PET/CT疗效评估:放射性改变的常见变异与潜在陷阱

Response Evaluation Following Radiation Therapy With 18F-FDG PET/CT: Common Variants of Radiation-Induced Changes and Potential Pitfalls.
PubMed 文献 · Semin Nucl Med · 2022-07-11

放射治疗是癌症治疗的基石之一,约半数患者在其癌症管理过程中会接受某种形式的放疗。放疗后采用18F-FDG PET/CT进行疗效评估和随访影像学检查时,可能因放疗诱导的急性、慢性或后续效应而变得复杂。普遍共识认为,放疗完成后18F-FDG PET/CT疗效评估应延迟12周进行,以尽量减少假阳性结果的风险。

要点

  • 放疗后18F-FDG PET/CT疗效评估普遍共识应延迟12周进行,以减少假阳性。
  • 放疗诱导的正常组织晚期副作用可历经数年发展,影像上可模拟复发疾病。
  • 放射性损伤的影像表现取决于受照体积内正常组织及放疗方案(总剂量、分次剂量、治疗日程)。

核心结论

  • 18F-FDG PET/CT对放疗后患者的疗效评估和随访非常有用,但变异和陷阱常见,放射性损伤常为排除性诊断。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 放疗后18F-FDG PET/CT疗效评估可受放疗诱导的急性、慢性或后续效应影响而复杂化。
  • 放射性损伤的影像表现取决于受照体积内包含的正常组织以及放疗方案,包括总剂量、分次剂量和治疗日程。
  • 正常组织放射性晚期副作用可历经数年发展并最终引起症状,影像上可潜在模拟复发疾病。
  • 放疗野内外科手术后的解剖改变和后遗症可进一步扭曲影像表现。
  • 长期癌症生存者中,放射暴露致癌效应导致的第二原发恶性肿瘤不应被忽视。

关键数值与推荐

  • 普遍共识认为,放疗完成后18F-FDG PET/CT疗效评估应延迟12周进行,以尽量减少假阳性结果的风险。
  • 评估影像疗效时应考虑放疗意图,即姑息性vs根治性或新辅助vs辅助放疗。

临床怎么用

  • 解读18F-FDG PET/CT时应认识常见的PET/CT诱导改变/损伤,并获取完整病史,因患者偶尔因与既往放疗恶性肿瘤无关的原因接受扫描。
  • 放射性损伤常为排除性诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiation therapy (RT) is one of the cornerstones in cancer treatment and approximately half of all patients will receive some form of RT during the course of their cancer management. Response evaluation after RT and follow-up imaging with 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) can be complicated by RT-induced acute, chronic or consequential effects. There is a general consensus that 18F-FDG PET/CT for response evaluation should be delayed for 12 weeks after completing RT to minimize the risk of false-positive findings. Radiation-induced late side effects in normal tissue can take years to develop and eventually cause symptoms that on imaging can potentially mimic recurrent disease. Imaging findings in radiation induced injuries depend on the normal tissue included in the irradiated volume and the radiation therapy regime including the total dose delivered, dose per fraction and treatment schedule. The intent for radiation therapy should be taken in consideration when evaluating the response on imaging, that is palliative vs curative or neoadjuvant vs adjuvant RT. Imaging findings can further be distorted by altered anatomy and sequelae following surgery within the radiation field. An awareness of common PET/CT-induced changes/injuries is essential when interpreting 18F-FDG PET/CT as well as obtaining a complete medical history, as patients are occasionally scanned for an unrelated cause to previously RT treated malignancy. In addition, secondary malignancies due to carcinogenic effects of radiation exposure in long-term cancer survivors should not be overlooked. 18F-FDG PET/CT can be very useful in response evaluation and follow-up in patients treated with RT, however, variants and pitfalls are common and it is important to remember that radiation-induced injury is often a diagnosis of exclusion.

来源:Semin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Dejanovic D, Specht L, Czyzewska D, et al. Response Evaluation Following Radiation Therapy With 18F-FDG PET/CT: Common Variants of Radiation-Induced Changes and Potential Pitfalls. Semin Nucl Med. 2022. PMID: 35835618. doi:10.1053/j.semnuclmed.2022.06.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。